Item(by='mikepurvis', descendants=None, kids=[25934441], score=None, time=1611782959, title=None, item_type='comment', url=None, parent=25933991, text='If the incumbent is a large scale pharmaceutical company with thousands of drugs in its portfolio, then it can most definitely afford to lose money under-cutting you when you only make a small handful.<p>And I think that really just underscores why this approach is the Google Fiber of the US pharma marketâ€” it may be able to force prices down for a handful of select customers, and may be helpful for proving a point about true costs and the need for regulation, but its existence is most certainly not some kind of proof of the invisible hand stepping in to solve this problem on its own and that regulation is therefore unnecessary.')